HER2 Support Group Forums - View Single Post - FDA clears Agendia's breast cancer recurrence assay

News · 02-23-2011, 09:41 PM

Agendia, a world leader in molecular cancer diagnostics, today announced that the company has received its fifth U.S. Food and Drug Administration clearance for MammaPrint, its widely used breast cancer recurrence assay.

More...

02-23-2011, 09:41 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,016	FDA clears Agendia's breast cancer recurrence assay Agendia, a world leader in molecular cancer diagnostics, today announced that the company has received its fifth U.S. Food and Drug Administration clearance for MammaPrint, its widely used breast cancer recurrence assay. More...